CareRx Corporation

DB:29C1 Stock Report

Market Cap: €81.6m

CareRx Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:29C1 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Nov 24Buy€14,795Maria PerrellaIndividual11,000€1.35
10 Sep 24Buy€7,063Jeff WatsonIndividual5,700€1.24
09 Sep 24Buy€26,678Keith McIntoshIndividual20,500€1.30
16 Aug 24Buy€7,711Kevin DaltonIndividual5,500€1.41
05 Jun 24Sell€44,278Andrew MokIndividual29,408€1.55
22 May 24Sell€21,728Andrew MokIndividual14,724€1.57
27 Mar 24Buy€31,794Jeff WatsonIndividual25,000€1.27
19 Mar 24Buy€16,669Kevin DaltonIndividual13,000€1.36

Insider Trading Volume

Insider Buying: 29C1 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 29C1?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,213,4672.02%
Private Companies6,040,02110.1%
Hedge Funds10,095,10716.8%
General Public20,965,39735%
Institutions21,640,57436.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 15 shareholders own 65.03% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.4%
Yorkville Asset Management Inc.
14,634,639€19.9m0%14.7%
16.8%
Polar Asset Management Partners Inc.
10,095,107€13.7m0%0.53%
10.3%
Seymour Investment Management Ltd.
6,202,101€8.4m0%16.78%
10.1%
Remedy Capital Corporation
6,040,021€8.2m0%no data
1.42%
Travis Featherstone
852,174€1.2m0%no data
1.33%
PenderFund Capital Management Ltd.
794,630€1.1m0%0.33%
0.32%
Kevin Dalton
193,433€263.2k321%no data
0.083%
Paul Rakowski
50,000€68.0k0%no data
0.058%
Keith McIntosh
34,700€47.2k0%no data
0.051%
Jeff Watson
30,700€41.8k0%no data
0.035%
Maria Perrella
21,000€28.6k110%no data
0.033%
Davide Pernarella
19,960€27.2k0%no data
0.015%
Dimensional Fund Advisors LP
9,204€12.5k0.01%no data
0.011%
Puneet Khanna
6,500€8.8k0%no data
0.0083%
Matthew Hills
5,000€6.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 16:00
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CareRx Corporation is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Doug CooperBeacon Securities Limited
David MartinBloom Burton & Co.
Prasath PanduranganBloom Burton & Co.